| Literature DB >> 36176618 |
Shanghui Huang1, Xiangqian Hong2,3, Mingyi Zhao4, Nanbo Liu4, Huiling Liu1, Jun Zhao3,5, Longquan Shao6, Wei Xue1, Han Zhang2, Ping Zhu4, Rui Guo1.
Abstract
Nanomaterials' unique structures at the nanometer level determine their incredible functions, and based on this, they can be widely used in the field of nanomedicine. However, nanomaterials do possess disadvantages that cannot be ignored, such as burst release, rapid elimination, and poor bioadhesion. Hydrogels are scaffolds with three-dimensional structures, and they exhibit good biocompatibility and drug release capacity. Hydrogels are also associated with disadvantages for biomedical applications such as poor anti-tumor capability, weak bioimaging capability, limited responsiveness, and so on. Incorporating nanomaterials into the 3D hydrogel network through physical or chemical covalent action may be an effective method to avoid their disadvantages. In nanocomposite hydrogel systems, multifunctional nanomaterials often work as the function core, giving the hydrogels a variety of properties (such as photo-thermal conversion, magnetothermal conversion, conductivity, targeting tumor, etc.). While, hydrogels can effectively improve the retention effect of nanomaterials and make the nanoparticles have good plasticity to adapt to various biomedical applications (such as various biosensors). Nanocomposite hydrogel systems have broad application prospects in biomedicine. In this review, we comprehensively summarize and discuss the most recent advances of nanomaterials composite hydrogels in biomedicine, including drug and cell delivery, cancer treatment, tissue regeneration, biosensing, and bioimaging, and we also briefly discussed the current situation of their commoditization in biomedicine.Entities:
Keywords: bioimaging; biosensing; cancer treatment; drug and cell delivery; nanocomposite hydrogels; tissue regeneration
Year: 2022 PMID: 36176618 PMCID: PMC9471997 DOI: 10.1002/btm2.10315
Source DB: PubMed Journal: Bioeng Transl Med ISSN: 2380-6761
FIGURE 1Schematic diagram of the main content of this review. Nanomaterials can be divided into zero‐dimensional materials (0DM), one‐dimensional materials (1DM), and two‐dimensional materials (2DM) according to their size, length‐diameter ratio, and diameter‐thickness ratio. Based on the polymer composition, hydrogels can be distributed into the natural polymer, synthetic polymer, and composite polymer hydrogels. According to the macroscopic phenotype of the composite systems, nanomaterials and hydrogels mainly combined into four composite systems, including nanocomposite hydrogel microneedles (MNs), injectable nanocomposite hydrogels, self‐healing nanocomposite hydrogels and bioimaging nanocomposite hydrogels. We reviewed the recent advances and future challenges of the composite systems, which almost involve all areas of biomedicine, including drug and cell delivery, cancer treatment, tissue regeneration, biosensing, and bioimaging
Representative nanomaterials and hydrogels
| Nano and gel | Class | Materials | Properties | Behaviors | Shortcomings | References |
|---|---|---|---|---|---|---|
| Nanomaterials | 0DM | Au NPs | Nanograde solid gold particles | Photothermal properties, biological imaging, electrical conductivity | Poor adhesion, easy to be removed, particle precipitation |
|
| MSNs NPs | Nano‐mesoporous structure | Drug loading capacity | Poor adhesion, easy to be removed, particle precipitation |
| ||
| Ag NPs | Nanograde solid silver particles | Antimicrobial ability, anti‐tumor | Poor adhesion, easy to be removed, particle precipitation |
| ||
| TiO2 NPs | Crystalline/amorphous nuclear shell structure | Photothermal properties, photodynamic properties | Poor adhesion, easy to be removed, particle precipitation |
| ||
| 1DM | CNCs | Cellulose nano‐rods | High surface energy, mechanical enhancement performance | Poor adhesion, easy to be removed, particle precipitation |
| |
| Au NWs | Linear nanogold fiber | High aspect ratio, unique electrical, optical, and magnetism | Poor adhesion, easy to be removed, particle precipitation |
| ||
| CNTs | Hollow fibrous structure with nano radial size | Good electrical and chemical properties, high modulus, and high strength | Poor adhesion, particle precipitation |
| ||
| 2DM | GO NSs | Two‐dimensional graphene oxide nanosheets, single or multiple layers | Photothermal properties, antibacterial activity, and drug loading properties | Poor adhesion, easy to be removed, particle precipitation |
| |
| BP NSs | Two‐dimensional black phosphorus nanosheets, single or multiple layers | Photothermal properties, photodynamic properties, drug‐loading properties, and biological imaging | Poor adhesion, easy to be oxidative degradation, particle precipitation |
| ||
| MXene NSs | Two‐dimensional transition metal nanosheets, single or multiple layers | High electrical conductivity, photoelectromagnetic characteristics, and mechanical enhancement capability | Poor adhesion, easy to be removed, particle precipitation |
| ||
| Hydrogels | Natural polymer hydrogels | Chitosan | Cationic polysaccharide | Antibacterial activity, 3D scaffold, and drug loading capability | Weak mechanical property, required in combination with drugs or cells |
|
| Dextran | Nonionic polysaccharide | High water content, 3D scaffold, drug loading capability | Weak mechanical property, required in combination with drugs or cells |
| ||
| Cellulose | Nonionic polysaccharide | High water content, 3D scaffold, drug loading capability | Required in combination with drugs or cells |
| ||
| Alginate | Ca2+ Sensitive natural polysaccharide | High water content, 3D scaffold, drug loading capability | Required in combination with drugs or cells |
| ||
| Synthetic polymer hydrogels | Poly(caprolactone)–poly(ethyleneglycol)–poly(caprolactone) | Temperature‐sensitive synthetic polymers | Injectability, 3D scaffold, drug loading capability | Required in combination with drugs or cells |
| |
| Poly(acrylamide‐ | Rich in hydrogen bonds | Self‐healing, drug loading capability, high mechanical strength, stretching ability, 3D scaffold | Required in combination with drugs or cells |
| ||
| Polymethyl vinyl ether‐salt‐maleic acid | hydrophilic group (—COOH) | Large swelling capacity, 3D scaffold, drug loading capability | Required in combination with drugs |
| ||
| Composite polymer hydrogels | Methacrylate‐modified gelatin and hyaluronic acid grafting dopamine | Photopolymerizable double bond, hydrophilic group (—OH, —NH2, —COOH) | Injectable, 3D scaffold, drug loading capability, adhesion | Required in combination with drugs |
| |
| Quaternized chitosan and dextran | Dynamic chemical bond (Schiff base bond) | Self‐healing, 3D scaffold, drug loading capability | Weak mechanical property, required in combination with drugs |
| ||
| 3‐Aminophenylboronic acid, aniline, and polyvinyl alcohol | Ultramolecular assembly of hydrogels, dynamic bonds (hydrogen bonding and π–π stacking) | Self‐healing, 3D scaffold, drug loading capability, electric conduction | Required in combination with nanoparticles to expand or enhance performance |
|
FIGURE 2Representative samples of nanomaterials and hydrogels. (a) TEM image of Au NPs@SiO2 (0DM). (b) SEM image and schematic diagram of CNTs (1DM). (c) Atomic force microscopy (AFM) image of single‐layer GO flake (2DM). (d) SEM image of Chitosan/β‐glycerophosphate sodium hydrogel. (e) An image of injectable poly(caprolactone)‐poly(ethylene glycol)‐poly (caprolactone) thermosensitive hydrogel. (f) Photographs showing the self‐healing ability of hydrogel prepared by quaternized chitosan and oxidized dextran.
FIGURE 3MN patch based on anoxia and H2O2 bio‐sensitive nanovesicles (d‐GRP) for intelligent delivery of insulin. (a) The synthesis and mechanism of nanovesicles (d‐GRP). (b) MNs patch loaded with non‐H2O2‐responsive GRP will induce local inflammation. The MN patch loaded with hypoxic and H2O2 dual‐sensitive d‐GRP can effectively avoid local inflammation.
FIGURE 4(a) Cell sampling microneedles could be used for analyzing cellular and humoral immune reactions in series. (b) Principles of microneedle patches and electrochemical microfluidic systems. (c) Separable MNs loaded with black phosphorus (BP) and oxygen carrier for promoting wound healing.
FIGURE 5(a) Preparation of BP NSs composite hydrogels. (b) Diagrammatic sketch of DOX @ Pd hydrogel and the chemical‐photothermal combined treatment. The NIR cannot only activate 2D Pd NSs' PTT capability, but it can also promote the release of DOX within the gel. (c) The working principle of MHZ gels. (a) Preparation path of MHZ gels. (b) Magnetocaloric response and the ROS mechanism for the synergistic treatment of tumor. (d) Diagrammatic sketch of tumor immunotherapy after hydrogel encapsulation of nano‐vaccine and nano‐drug. Continuous release of nano‐drug could achieve chemotherapy and promote the recruitment of host cells. At the same time, nano‐vaccines could deliver antigens to DCs and mature these cells.
FIGURE 6(A) Design and characterization of fullerenol/alginate gel. (a) Gelation and design of fullerenol/alginate gel. Clearance of fullerenol/alginate gel toward (b) hydroxy and (c) DPPH radicals. (b) The working mechanism of Anisogel hydrogel. The cells strongly sense the resulting macroscopic unidirectional orientation, thus causing parallel nerves to stretch. (c) The BMSC and Mg particles were encapsulated in the hydrogel. (d) PRP‐chitosan thermal response hydrogel composite BP NSs can be used for the biological treatment and phototherapy (PTT, PDT) of rheumatoid arthritis.
FIGURE 7(a) The design route and the original, curved, compressed, and self‐healing forms of rGO nanocomposite gel and their application in full‐thickness skin wound healing. Scale bar: 5 mm. (b) The preparation process of injectable thermosensitive hydrogel (FEP@exosomes) and its antibacterial ability, rapid hemostasis, anti‐ultraviolet activity, and diabetes wound repair properties (a). FEP@exo hydrogel can stimulate angiogenesis in diabetic wound tissue. Immunofluorescence staining of α‐SMA (b) and of neovascularization (c) on Day 7. Scale bar: 20 μm. (c) The synthesis route of FCB hydrogel and its effect in cancer treatment and wound repair. (d) (a) Gold NPs or NRs are introduced to create two DNA‐based hydrogels. The hydrogels can be used to develop light‐controlled mechanical properties and to promote shape memory, light‐controlled drug release, and self‐healing through on/off irradiation. (b, c) Controlled release of DOX from hydrogels with (Curve a) or without laser irradiation (Curve b).
Representative nanocomposite hydrogels for biomedical applications
| Composite systems | Application | Nanomaterials | Hydrogels | Properties | Mechanism | References |
|---|---|---|---|---|---|---|
| Nanocomposite hydrogel micro‐needle patches | Intelligent insulin delivery | Polymer nanovesicle NPs | Cross‐linked hyaluronic acid (HA‐MA) | Painless and intelligent regulation of blood glucose balance | Nanovesicle can amplify the blood glucose signal |
|
| Polymer nanovesicles NPs | HA‐MA | Response to H2O2 and painless drug delivery | The nanoparticles can response to H2O2 |
| ||
| Polymer nanovesicles NPs | HA‐MA | Response to hypoxic and H2O2, reduce inflammation | The nano‐particles can response to hypoxic and H2O2 |
| ||
|
Nano‐Micelles NPs | PVA | Response to H2O2 and painless drug delivery | The nano‐particle can eliminate H2O2, thus reducing inflammation |
| ||
| Sampling interstitial fluid | Nano‐Capsules NPs | Alginate | Painless Sample interstitial fluid and immunocyte | Molecular adjuvants and specific antigens were encapsulated in nanocapsules, can capture specific immune cells |
| |
| Au NWs | Polymethyl vinyl ether‐salt‐maleic acid | Real‐time quantitative assay of EBV‐Cf DNA | Hydrogel swells, Au NWs can conduct electricity |
| ||
| Wound healing | BP NPs | GelMA | Promote wound healing | The photothermal effect of BP results in the release of O2, to promote wound healing. |
| |
| Injectable nanocomposite hydrogels | Cancer treatment | BP NSs | Cellulose | PTT | Local high temperature killed the tumor cells |
|
| B‐TiO2‐x NPs | Chitosan | PDT and PTT synergistic therapy | Reactive oxygen species and high‐temperature anti‐tumor |
| ||
| Fe3O4@PEI NPs | Poly(lactic‐ | Magnetic heat and ROS synergistic therapy | Fe3O4@PEI NPs can produce high temperature and ROS in response to magnetic field |
| ||
| Dendritic NPs | Poly( | Chemotherapy and immunotherapy synergistic therapy | Dendritic NPs integrate the anti‐tumor drug DOX and arginine‐rich molecules |
| ||
| Myocardial tissue engineering | Fullerenol NPs | Alginate | Increase stem cell survival, enhance angiogenesis | Fullerenol NPs can eliminate ROS, thus increasing stem cell survival |
| |
| Nerve tissue engineering | USPIO NPs | Star‐PEG‐A | Minimally invasive injection, can induce directional cell growth | In situ gelation, USPIO NPs can response to extracorporeal magnetic field |
| |
| Bone tissue engineering | Nanoclay NSs | Methacrylated glycol chitosan | High mechanical strength, without loading cells and growth factors | Nanoclay NSs have charge interaction with the gel matrix, the complex can recruit native cells for bone regeneration |
| |
| Cartilage tissue engineering | BP NSs | Chitosan | Injectable, PTT/PDT multifunctional treatment platform | Chitosan has temperature‐sensitive property, PTT can remove hyperplastic synovial tissue, PDT can stimulate the regeneration of cartilage injury |
| |
| Skin tissue engineering | Exosomes NPs | Aldehydepullulan (APu) and Pluronic F‐127 | Injectable, in response to the pH releasing exosomes | F‐127 has temperature‐sensitive property, the electrostatic action of exosomes‐PEI is destroyed in acidic environment |
| |
| Self‐healing nanocomposite hydrogels | Controlled drugs release | Au NPs or Au NRs | Polyacrylamide | Laser‐controlled drugs release | Photothermal effect resulting in the crosslinking decrease of hydrogel to release the drug |
|
| Bionic electronic skin | Proanthocyanidin (PC)/rGO NPs | Glycerol‐PVA‐borax | Super‐stretchability, instant self‐healing ability, simulating the touch of natural skin | Glycerol chelates with borax and forms hydrogen bond with PVA. PC/rGO provides electrical conductivity for composites |
| |
| Glucose sensor | CeO2/MnO NPs | Quaternized chitosan composite oxidized dextran | Rapid and sensitive response to glucose, self‐healing property | CeO2/MnO2 NPs act as electrocatalytic medium, Schiff base bond between quaternized chitosan and oxidized dextran |
| |
| Strain sensor | GO NSs and Ag NWs | PVA/Ca2+ | Strong mechanical toughness, self‐healing property, conductivity | Ag NWs endow the sensor system with high conductivity, The PVA‐Ca2+ ‐GO network forms a large number of hydrogen bonds |
| |
| Bioactuator | Boron nitride NSs | Poly(acrylamide‐ | Self‐healing property, tensile strength and toughness, frost and high‐temperature resistance | A large number of irregular hydrogen bonds formed by glycerol‐polymer‐water network |
| |
| Bioimaging nanocomposite hydrogels | Antitumor bioimaging | Ag2S NPs | Coiled‐coil polypeptides | Monitor hydrogel degradation at tumor sites dynamically | Ag2S NPs can perform photoacoustic and fluorescence bioimaging |
|
| Tissue engineering bioimaging | USPIOs NPs | Ellulose nanocrystal/dextran | Noninvasive monitoring of bone | USPIOs can response to in vitro MRI |
| |
| Cell behavior bioimaging | Ag NPs | Polymeric DNAs with cytosine‐rich sequences | Monitoring active oxygen species and nitrogen substances in living cells | Strong oxidant decreased the red fluorescence and enhanced the green fluorescence of Ag NPs |
|
Note: NPs (nanoparticles), NRs (nanorods) belong to 0DM; NWs (nanowires) belong to 1DM; NSs (nanosheets) belong to 2DM.
FIGURE 8(a) Design diagrammatic sketch of a PC/rGO/PVA gel. (b) (a) The PVA meshwork, (b) the borax‐glycerol‐water meshwork, and (c) the neuroid PC/rGO meshwork. (c) (a) The SEM image of the PC/rGO meshwork, (b) the distribution of tactile nerves in the skin. (d) The PC/rGO/PVA gel can be modeled into multiple shapes. (e) The gel can dynamically adapt to finger movements (scale bar: 5 cm).
FIGURE 9(A) (a) Diagrammatic sketch and photograph of a glucose electrode. (b) Schematic diagram of the construction of glucose sensors. (c) Physical photographs of the assembled glucose sensor. (d) The sensor can respond to the repetitive addition of 4 and 8 mM glucose. (b) (a) Gels in which partial water is replaced (MNOH) are more resistant to low temperatures than pure hydrogels (MNH). (b) MNOH‐based sensors' strain–resistance correlation curves. Sensors resistance responds to small strains (c) and to large strains (d), respectively. The sensors could still respond to fingers bending (e) and to throat movement (f) after being stored at −40°C for 6 h. (c) The synthesis procedure of PDA@Ag NPs/CPH hydrogels and their application in monitoring motions and diabetic wound repair. (d) (a) The design routes for P(AM‐co‐MAH)/f‐BNNS glycerol‐hydrogels. (b) Response braking process of the double‐layer gel. (c) Grab, lift, and release triggered by different temperatures.
FIGURE 10(A) (a) The degradation of hydrogel scaffolds in vitro and in vivo by FLI. (b) The degradation of hydrogel scaffolds in vivo by PAI. (b) (a) The PLNP nanocomposite hydrogel targets and tracks tumor metastasis. (b) Sustained fluorescence images of tumor cells labeled with PLNPs‐CPBA to assess their tumor migration process. (c) Long‐lasting luminous image of mouse organs in vitro. (d) Semi‐quantitative analysis of continuous luminescence from different isolated organs. (c) Engineering design of 3D heart tissue operated through a magnetic field. (a, b) Diagram of the experimental procedure. (c, d) Magnetic field and force distribution of the different magnets. (e–j) The bright field and fluorescent images of the patterned tissue in response to different magnetic fields. (k–m) The control hydrogel without applying a magnetic field revealed the random distribution of CMs within the hydrogel. Scale bar: 1 mm. (d) (a) The images of O2 concentration distribution in the scaffold with or without light. (b) After 60 min of illumination or 30 min of darkness, the distribution of O2 concentration in the vertical direction of the scaffold was observed.
Representative products of nanomaterials or hydrogels
| Products | Class | Application | Materials | Company |
|---|---|---|---|---|
| Restylane | Medical device (Class III) | Injectable dermal filler | Consists of hyaluronic acid (HA) hydrogel | Medicis Aesthetics Holdings, Inc |
| SpaceOAR Vue | Medical device (Class II) | Reduce the radiation dose delivered to the anterior rectum | Consists of absorbable polyethylene glycol (PEG)‐based hydrogel | Augmenix, Inc. |
| Zenieva | Medical device (Class I) | Wound dressing | Consists of crosslinked polyacrylic acid hydrogel | River's Edge Pharmaceuticals, LLC |
| NanoTite | Medical device (Class II) | Dental implants | Calcium phosphate nanoparticles | Implant Innovations, Inc. |
| NanoBone | Medical device (Class II) | Bone void filler | Nanocrystalline hydroxylapatite | ARTOSS GmbH |
| COBRA PzF | Medical device (Class III) | NanoCoated Coronary Stent | Polymeric polyphosphazene nanocoating | CeloNova BioSciences, Inc. |
| DEXTENZA | New drug | Treatment of eye inflammation | PEG‐based hydrogel contains dexamethasone | Ocular Therapeutix |
| VANTAS | New drug | Treatment of prostate cancer | Diffusion‐controlled hydrogel containing histrelin acetate | ENDO |
| SUPPRELIN LA | New drug | Children with central precocious puberty (CPP) | Hydrogel containing histrelin acetate | Indevus |
| RenaGel | New drug | Hyperphosphatemia | Hydrogel containing with sevalamer hydrochloride | GelTex Pharmaceuticals Inc. |
| DOXIL | New drug | Advanced ovarian cancer, multiple bone marrow cancer, and so on | Lipid‐based nanoparticles, liposomes (150–250 nm) loaded with DOX | Sequus Pharmaceuticals |
| mRNA‐1273 | New drug | COVID‐19 vaccine | Lipid‐based nanoparticles, liposomes loaded with mRNA | Moderna |
| ADYNOVA‐TE | New drug | Hemophilia | Polymer‐based nanoparticles, PEGylated recombinant antihemophilia factor | Takeda |
| DexFerrum | New drug | Iron‐deficient anemia | Inorganic nanoparticles, iron dextran colloid | American regent |
| Abraxane | New drug |
Advanced non‐small cell lung cancer Metastatic breast cancer (secondary) Metastatic pancreatic cancer (primary) | Protein‐based nanoparticles, albumin‐particle bound paclitaxel | Celgene |
| Feridex I.V. | New drug | Imaging of liver lesions | Inorganic nanoparticles, iron dextran colloid | AMAG |